Type 2 & other diabetes

Triglyceride-glucose-body mass index and the incidence of cardiovascular diseases: a meta-analysis of cohort studies

Cardiovasc DiabetolPublished Systematic review and meta-analysis of cohort studies

Pooled result · CVDResult — go to the resultHazard ratio 1.62 95% CI 1.35–1.95

Authors' conclusion

Higher TyG-BMI may be independently associated with an increased risk of CVD in individuals without CVD at baseline. Numerous cohort studies are needed to further validate and elucidate the pathologic role between Tyg-BMI and CVD and to determine whether it can be incorporated into CVD risk prediction tools to enhance predictive accuracy.

Study context

Population
Individuals without CVD at baseline
Participants
871,728 individuals10 cohort studies
Comparison
Highest vs lowest TyG-BMI index category
Outcome
Incidence of CVD
Methodological detailsrandom-effects model, dose-response meta-regression
  • Random-effects model
  • Dose-response meta-regression

Pooled result

CVD

Hazard ratio

1.62

95% CI 1.35–1.95

Highest TyG-BMIvs Lowest TyG-BMI
HR 1.62 (95% CI 1.35–1.95)

As reported in the abstract

Further pooled results

OutcomeHR (95% CI)
CADI2 = 94%1.69 (1.23–2.31)
StrokeI2 = 94%1.57 (1.11–2.23)

Dose-response: TyG-BMI index and risk

Linear association with CVD risk
Pnonlinear = 0.223
Linear association with coronary artery disease (CAD) risk
Pnonlinear = 0.693
Linear association with stroke risk
Pnonlinear = 0.122

Subgroups: gender, follow-up length, sample size, mean age

No significant effects observed
P > 0.05

Original publication

Triglyceride-glucose-body mass index and the incidence of cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. Published 22 January 2025. doi:10.1186/s12933-025-02584-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.